1. Home
  2. OLB vs PULM Comparison

OLB vs PULM Comparison

Compare OLB & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The OLB Group Inc.

OLB

The OLB Group Inc.

BUY

Current Price

$0.19

Market Cap

7.4M

Sector

Technology

ML Signal

BUY

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

N/A

Current Price

$1.54

Market Cap

6.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OLB
PULM
Founded
1993
2003
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
6.2M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
OLB
PULM
Price
$0.19
$1.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 7.1M
46.4K
Earning Date
11-13-2026
10-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 71.48
46.18
EPS
★ N/A
N/A
Revenue
★ $8,676,907.00
$7,910,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$67.27
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 5069.93
52 Week Low
$0.18
$1.16
52 Week High
$1.80
$5.24

Technical Indicators

Market Signals
Indicator
OLB
PULM
Relative Strength Index (RSI) 32.84 48.60
Support Level $0.18 $1.44
Resistance Level $0.34 $1.55
Average True Range (ATR) 0.02 0.10
MACD -0.00 0.00
Stochastic Oscillator 10.59 37.87

Price Performance

Historical Comparison
OLB
PULM

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified FinTech company that focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. The company seeks to provide merchants with a wide range-of-products and services through the various online platforms, including financial and transaction processing services. It also has products that provide support for crowdfunding and other capital-raising initiatives. It supplements the online platforms with certain hardware solutions that are integrated with the online platforms. The company has two business segments: Fintech Services, which generates key revenue, and the Bitcoin Mining business segment.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: